The North America Ureteroscopy Market would witness market growth of 4.5% CAGR during the forecast period (2022-2028).
Ureteroscopy is often an outpatient procedure, but if it takes a long time or is problematic, patients might need to spend the night in the hospital. Under some circumstances, such as ureteral or kidney stones, tumor in the ureter or pelvis, hematuria brought on by kidney stones, the presence of foreign bodies, biopsies, ureterovaginal fistula, and others, the doctor may advise the patient to have the procedure. A tumor is a mass that develops due to aberrant cell development. Urinary obstruction may result from a tumor inside the kidneys or close to the ureter.
A conservative method of treating tumors is offered via ureteroscopy, particularly when surgical methods are prohibited. Blood in the urine is referred to as hematuria. One of the reasons for hematuria is kidney stones. Furthermore, hematuria can be treated by removing the stones by ureteroscopy. Most foreign bodies are catheter pieces or other objects that obstruct the passage of urine. These pieces are accessible during ureteroscopy, allowing for effective retrieval.
There were roughly 54.1 million elderly Americans aged 65 and over in the United States in 2019. This constitutes roughly 16% of the overall population, more than one in every seven Americans. From 2009 to 2019, there were 14.4 million more elderly individuals. Furthermore, according to census figures, one in four Americans will be 65 or older or older by 2060. Three times as many people will be 85 and older than there are now. Moreover, there were approximately 6 million seniors in Canada in 2014, or 15.6% of the country's population. Also, the government projects that by 2030, there will be 9.5 million seniors in the country or 23 percent of the entire population. The demand for ureteroscopy in the local market would increase as a result.
The US market dominated the North America Ureteroscopy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $304.6 Million by 2028. The Canada market is poised to grow at a CAGR of 6.5% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.3% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Flexible, and Semi- Rigid. Based on Application, the market is segmented Urolithiasis, Urinary Stricture, Kidney Cancer, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America
Free Valuable Insights: The Global Ureteroscopy Market is Estimated to reach $1.1 Billion by 2028, at a CAGR of 5.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Steris PLC, Stryker Corporation, Advin Health Care, Karl Storz SE & Co. KG, Richard Wolf GmbH, Cliniva Healthcare, and OTU Medical Inc.
By End User
By Product
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
